
|Articles|September 1, 2002
The American Journal of Managed Care
- September 2002
- Volume 8
- Issue 9
A Word From the New Editors
Author(s)A. Mark Fendrick, MD, Michael E. Chernew, PhD
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
2
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
Making the Genetic Models Match the Ancestry of Patient Populations
5














































